Delayed
Bombay S.E.
00:31:04 2024-05-08 EDT
|
5-day change
|
1st Jan Change
|
376.8
INR
|
+1.60%
|
|
-5.48%
|
+9.31%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,180
|
1,004
|
905.3
|
3,604
|
3,883
|
2,243
|
Enterprise Value (EV)
1 |
1,241
|
1,026
|
796.9
|
3,464
|
4,392
|
2,562
|
P/E ratio
|
12.2
x
|
13
x
|
9.85
x
|
41
x
|
350
x
|
-10.6
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.73
x
|
3.05
x
|
2.78
x
|
11.8
x
|
8.93
x
|
3.66
x
|
EV / Revenue
|
3.92
x
|
3.12
x
|
2.44
x
|
11.4
x
|
10.1
x
|
4.18
x
|
EV / EBITDA
|
10.1
x
|
8.32
x
|
5.71
x
|
30.8
x
|
111
x
|
-45.7
x
|
EV / FCF
|
98.3
x
|
229
x
|
7.06
x
|
72.6
x
|
-7.01
x
|
-12.9
x
|
FCF Yield
|
1.02%
|
0.44%
|
14.2%
|
1.38%
|
-14.3%
|
-7.73%
|
Price to Book
|
13.7
x
|
6.14
x
|
3.55
x
|
10.5
x
|
11
x
|
3.28
x
|
Nbr of stocks (in thousands)
|
9,425
|
9,425
|
9,425
|
9,425
|
9,425
|
12,363
|
Reference price
2 |
125.2
|
106.5
|
96.05
|
382.4
|
412.0
|
181.4
|
Announcement Date
|
18-08-22
|
19-06-24
|
20-07-22
|
21-08-25
|
22-07-29
|
23-08-14
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
316.4
|
328.7
|
326
|
304.2
|
434.8
|
613.2
|
EBITDA
1 |
122.3
|
123.3
|
139.6
|
112.5
|
39.49
|
-56.05
|
EBIT
1 |
118.5
|
117.9
|
131.1
|
103
|
22.55
|
-123
|
Operating Margin
|
37.45%
|
35.88%
|
40.21%
|
33.84%
|
5.19%
|
-20.05%
|
Earnings before Tax (EBT)
1 |
97.04
|
99.8
|
126.9
|
108.1
|
16.2
|
-156.9
|
Net income
1 |
97.04
|
77.5
|
91.92
|
87.98
|
11.09
|
-161
|
Net margin
|
30.67%
|
23.58%
|
28.2%
|
28.92%
|
2.55%
|
-26.27%
|
EPS
2 |
10.30
|
8.220
|
9.752
|
9.334
|
1.177
|
-17.05
|
Free Cash Flow
1 |
12.62
|
4.478
|
112.9
|
47.69
|
-626.1
|
-198
|
FCF margin
|
3.99%
|
1.36%
|
34.62%
|
15.68%
|
-144.01%
|
-32.29%
|
FCF Conversion (EBITDA)
|
10.32%
|
3.63%
|
80.87%
|
42.41%
|
-
|
-
|
FCF Conversion (Net income)
|
13%
|
5.78%
|
122.78%
|
54.21%
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
18-08-22
|
19-06-24
|
20-07-22
|
21-08-25
|
22-07-29
|
23-08-14
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
60.8
|
22.2
|
-
|
-
|
509
|
319
|
Net Cash position
1 |
-
|
-
|
108
|
140
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.4971
x
|
0.1802
x
|
-
|
-
|
12.9
x
|
-5.695
x
|
Free Cash Flow
1 |
12.6
|
4.48
|
113
|
47.7
|
-626
|
-198
|
ROE (net income / shareholders' equity)
|
260%
|
62.2%
|
43.9%
|
29.4%
|
3.19%
|
-31.1%
|
ROA (Net income/ Total Assets)
|
36.2%
|
25.8%
|
24.4%
|
15.5%
|
1.9%
|
-7.03%
|
Assets
1 |
267.9
|
300.1
|
376
|
565.9
|
584.5
|
2,289
|
Book Value Per Share
2 |
9.120
|
17.30
|
27.10
|
36.30
|
37.50
|
55.30
|
Cash Flow per Share
2 |
3.370
|
0.1200
|
0.5500
|
0.5700
|
0.1300
|
2.320
|
Capex
1 |
9.43
|
31.1
|
11.2
|
73.2
|
628
|
160
|
Capex / Sales
|
2.98%
|
9.46%
|
3.45%
|
24.06%
|
144.42%
|
26.15%
|
Announcement Date
|
18-08-22
|
19-06-24
|
20-07-22
|
21-08-25
|
22-07-29
|
23-08-14
|
|
1st Jan change
|
Capi.
|
---|
| +9.31% | 54.95M | | +4.46% | 104B | | -3.35% | 64.55B | | +46.67% | 41.5B | | +19.71% | 40.01B | | +6.70% | 33.03B | | +11.78% | 20.11B | | +17.06% | 17.52B | | +20.73% | 15.51B | | +11.69% | 15.34B |
Other Commodity Chemicals
|